Scientists developed vaccines for COVID-19 in a matter of months. Why after 37 years do we still not have one for HIV/AIDS? On HIV Vaccine Awareness Day, it’s an important question to ask.
Rigor acadêmico, estilo jornalístico
Todos os artigos de HIV
Exibindo 81 - 100 de 378 artigos
The HIV In My Day project preserves the early history of the HIV/AIDS pandemic through the personal stories of long-term survivors and caregivers.
Cryptococcal ceningitis is one of the main causes of death of people with HIV. The tests and medicines to diagnose and treat it exist but remain inaccessible to most. A global strategy is needed.
This research provides fresh insights into strategies that can be used to improve the lives of adolescents in sub-Saharan Africa and around the world.
Narrow, unimaginative public health responses inhibit reducing HIV, exploitation and marginalisation within sex work.
Scientists around the world are trying to come up with universal coronavirus vaccines to combat the emergence of variants. But what are these vaccines and are they even possible?
New research highlights how the press excluded, shamed and invaded the privacy of those living with HIV.
Where there are not enough health workers to deliver medical care, one solution is to move certain tasks to less specialised health workers, a process called task-shifting.
COVID-19 restrictions created life-threatening challenges to female sex workers as they weren’t able to access their medication, support or their clients.
Local and national governments in west and central African countries must prioritise investment in providing access to HIV testing for all pregnant women.
The evidence shows that keeping girls in school not only reduces HIV risk, but also delays marriage and pregnancy, and improves mental health.
In both countries, neglect and misinformation at the highest levels of government led to undue tragedy.
Parents have the primary role of educating their children about their sexuality. But cultural beliefs and taboos about sex can work strongly against their efforts.
The HIV/AIDS response played out over a much longer trajectory than COVID-19. But it is, in some respects, a shining example of what can be achieved when countries and people work together.
If the world is single-minded and focuses purely on combating one pandemic, forgetting others, the effects of other morbidity and mortality on healthcare systems will be seen for a long time to come.
Nurses represent 50% of the global healthcare workforce. And they are often the sole healthcare providers in many low and middle-income countries.
Care for patients with more than one disease is fragmented and uncoordinated. This is can cost patients time, effort and lost wages.
One of the main challenges remains that diagnostics and drugs for people suffering from advanced HIV aren’t readily available. This group of people is vulnerable to deadly opportunistic infections.
As viruses are transmitted from person to person they are constantly mutating and replicating. Could the SARS-CoV-2 virus evolve to evade the new vaccines that have just been developed?
Our findings suggest that cabotegravir is much more effective than Truvada in preventing HIV infection in women.
Principais colaboradores
-
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
-
Associate Professor and Principal Research Fellow, Australian Research Centre in Sex, Health and Society, La Trobe University
-
Research Professor, Perinatal HIV Research Unit and President, South African Medical Research Council
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Senior lecturer, public health ethics, School of Population Health, UNSW Sydney
-
Honorary Research Associate, Centre for Infectious Disease Epidemiology and Research, University of Cape Town
-
Associate Professor, Monash University
-
Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, University of the Witwatersrand
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Scientia Professor of Medicine and Director, Kirby Institute, UNSW Sydney
-
Research Director at The Health Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal
-
Associate Professor and Head of the Surveillance and Evaluation Program for Public Health at the Kirby Institute, UNSW Sydney
-
Doctoral Researcher, School of Public Health and Public Health Technical Advisor, Anova Health Institute, University of the Witwatersrand
-
Research Scientist, African Population and Health Research Center
-
Professor of Gender Studies, Chair in Sex Media and Sex Cultures, Linköping University
